癌症中的Claudins:当前和未来的治疗目标
Caroline Hana1, Nyein Nyein Thaw Dar1, Michael Galo Venegas1
1Hematology/Oncology Department, Memorial Healthcare System, Pembroke Pines, FL 33028, USA.
International journal of molecular sciences
|May 11, 2024
概括
克劳丁是紧密结合中的关键蛋白质,影响细胞运动和癌症转移. 针对claudins,如claudin 18.2,显示了改善癌症治疗结果的希望.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 克劳丁是不可分割的膜蛋白质,对紧密结合的完整性至关重要.
- 这些蛋白质调节细胞透性,离子运输和细胞迁移.
- 克劳丁蛋白的失调与癌症的进展,入侵和转移有关.
研究的目的:
- 审查克劳丁在生物过程中的基本作用.
- 检查正常和癌症组织中claudins的表达模式.
- 为了探索针对癌症治疗的向claudins的治疗潜力.
主要方法:
- 关于克劳丁功能和表达的研究的文献综述.
- 对克劳丁向癌症治疗的研究分析.
- 关于克劳丁参与癌症转移的证据综合.
主要成果:
- 克劳迪因在上皮屏障功能和细胞信号传递中起着至关重要的作用.
- 异常的克劳丁表达是许多癌症的标志.
- 新兴疗法,包括单克隆抗体和向克劳丁的CAR T细胞,证明了治疗疗效.
结论:
- 克劳丁是癌症生物学中的重要参与者,影响转移和治疗反应.
- 针对特定的克劳丁,如克劳丁18.2,为新型癌症疗法提供了一个有前途的战略.
- 对基于克劳丁的治疗方法的进一步研究可能会在各种癌症中改善患者的治疗结果.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Tight Junctions
5.3K
Tight junctions are molecular seals between cells that prevent the leaking of fluids, ions, and other small solutes across cavities and compartments in multicellular organisms. They are mainly composed of claudin and occludin transmembrane proteins, and other proteins such as tricellulin and JAM (junctional adhesion molecule). All these proteins are 4-pass transmembrane proteins, except JAM, which is a single-pass transmembrane protein belonging to the immunoglobulin superfamily. The...
5.3K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K


